Photonics in Health Care – Application areas

photonics health

Photonics in Health Care – Application areas

Biophotonics is a new and fast growing discipline in the health care and life sciences industry. Biophotonics studies the interaction between light and human tissue. Using multiband photonic and spectroscopic methods it is able to analyze cells and tissues by the way these living structures absorb, reflect and scatter light. This can be used to diagnose and treat diseases ranging from cancer to strokes and Alzheimer’s.

The benefits of photonics in health care are plentiful. The technology is non-invasive and has no adverse side effects, as it only deploys a light beam for diagnosis and treatment. Medical devices based on photonics technology are small and easy to handle, making the treatment highly portable. Last but not least, the cost of photonics treatment is low.

Researchers have identified several health care fields where biophotonics technology is especially promising: Continue reading “Photonics in Health Care – Application areas”

“Medical Design Trends for Wearables” – Presented by Robert Newberry, Sanmina

Medical Design Trends for Wearables- Presented by Robert Newberry, Sanmina
With rapidly growing healthcare expenditures, aging populations, and rising lifestyle diseases it has increasingly put demands on medical design solutions which can provide a wide range of health information to be used across diagnostics, healthcare, and consumer markets.  In many cases optical sensors are being integrated into the next generation wearable devices in order to provide novel biometric information not previously available as an integrated solution. Continue reading ““Medical Design Trends for Wearables” – Presented by Robert Newberry, Sanmina”

“Unravelling Cancer: Photonics Technology for Liquid Biopsy Applications” – Presented by Jon Lind, Cambridge Consultants

Jon Lind, Cambridge Consultants, will present “Unravelling Cancer: Photonics Technology for Liquid Biopsy Applications” at the Health Tech Event, which will take place on May 25-26, 2016, at Tyndall National Institute in Cork, Ireland.

Liquid biopsy can revolutionise the future of cancer diagnostics and disease management. The biomarkers for cancer present in blood are very diluted and difficult to measure. Droplet digital PCR (dPCR) is a technique that can measure minute concentrations of biomarkers such as free circulating DNA fragments relevant to cancer diagnostics. The wide-spread adoption of dPCR has been held back by complicated workflow and slow read out times. We have developed a technology that seeks to address the slow read out times.

About Jon Lind Continue reading ““Unravelling Cancer: Photonics Technology for Liquid Biopsy Applications” – Presented by Jon Lind, Cambridge Consultants”

Nancy Westerlaken, TNO, presents about Van ‘t Hoff program

The Van ‘t Hoff program is a new collaborative research and innovation program, initiated by TNO, in the field of biomedical optics. The Van ‘t Hoff program develops biophotonics-based technologies to enable less invasive surgical procedures, better screening and monitoring of diseases in asymptomatic stages and better and/or personalized treatment for patients, leading to reduced healthcare costs and improved healthcare. The Van ‘t Hoff program forms an eco-system where industry, university hospitals, research institutes and health foundations collaborate in order to accelerate medical and technological innovations and their implementation in health care.